Seung-Woon Rha

Showing 1-8 of 8 articles

Coronary interventions

BioMatrix versus Orsiro Stent for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study

Yoon C, Choi YJ, Park J, Kang S, Kim S, Suh J-W, Cho Y-S, Youn T, Kim M, Cha KS, Lee S, Hong B-K, Rha S, Kang WC, Lee J-H, Kim S, Chae I, Lee N, Ahn K, Park H, Park D, Kim D, Kim H, Lym S, Seo YS, Chang K, Cha T, Hwang B, Cho B, Park B, Jeon H, Park J-S

September 29, 2020 | 10.4244/EIJ-D-20-00185

Coronary interventions

Multivessel percutaneous coronary intervention in patients with acute myocardial infarction and severe renal dysfunction

Song P, Hahn J, Gwon H, Jeon K, Yu C, Rha S, Yoon C, Jeong M

December 6, 2019 | 10.4244/EIJ-D-19-00034

Coronary interventions

Clinical outcomes of long stent in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry

Kong M, Han J, Kang J, Zheng C, Yang H, Park K, Kang H, Koo B, Chae I, Kim H, Choi YJ, Shin E, Bae J-W, Chun K-J, Kim D, Rha S, Lee S, Rhew JY, Woo S-I, Lee HC, Jeong J-O

September 24, 2019 | 10.4244/EIJ-D-19-00296

Coronary interventions

Impact of calcified bifurcation lesions in patients undergoing percutaneous coronary intervention using drug-eluting stents: results from the COronary BIfurcation Stent (COBIS) II registry

Kim M, Ahn Y, Sim D, Hong YJ, Kim J, Jeong M, Gwon H, Kim H, Rha S, Yoon J, Jang Y, Tahk S, Seung K

June 20, 2017 | 10.4244/EIJ-D-16-00264

Coronary interventions

Late-acquired incomplete stent apposition after everolimus-eluting stent versus sirolimus-eluting stent implantation in patients with non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction (APPOSITION-AMI)

Hur S-H, Lee B-R, Kim S, Hong Y, Bae J-H, Choi D, Kang H, Choi S-Y, Lee S, Kim D-I, Park J-S, Rha S

October 10, 2016 | 10.4244/EIJY15M09_12

Coronary interventions

Impact of non-compliant balloons on long-term clinical outcomes in coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II registry

Park TK, Lee J-H, Song YB, Jeong J-O, Hahn J, Yang J, Choi S, Choi J, Lee S, Jeong M, Kim H, Oh J.H., Yu C, Rha S, Jang Y, Yoon J, Tahk S, Seung K, Park J-S, Gwon H

July 20, 2016 | 10.4244/EIJV12I4A79

Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial

Kang W, Ahn T, Lee K, Han S, Shin E, Jeong M, Yoon J, Park J-S, Bae J, Hur S, Rha S, Oh S, Kim D, Jang Y, Choi J, Kim B

December 30, 2011 | 10.4244/EIJV7I8A148

Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials

Tamhane U, Meier P, Chetcuti S, Chen K, Rha S, Grossman M, Gurm H

August 14, 2009

1

Latest news

State-of-the-Art on Coronary Physiology; a Mini Focus on Biostatistics; Post-TAVI Aortic Manipulation; Minimally Invasive Ventricular Reconstruction after MI

Don't miss the next #EIJCardioChat!

IVUS-guided stenting in VIV-TAVI

Optimising Physiological Endpoints of Percutaneous Coronary Intervention

New update: OPTIMIZE PCI, EXAMINATION 10 years, BIONYX 2 years, SAFE A and more

(Thanks to the support of Biotronik)

Reducing refractory angina

Ranil de Silva et al.

Discover EuroIntervention's New Author Centre

Coronary flow reserve and coronary flow capacity at a time of shifting paradigms of ischaemic heart disease

Valvular disease